The disappearance of ring sideroblasts in myeloblastic leukaemia in remission.
D000328:Adult; D001215:Asparaginase / Q000627:therapeutic use; D001803:Blood Transfusion; D001853:Bone Marrow / Q000473:pathology*; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D004912:Erythrocytes / Q000378:metabolism; D004913:Erythrocytes, Abnormal; D005260:Female; D006801:Humans; D007501:Iron / Q000378:metabolism; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology* / Q000628:therapy; D015122:Mercaptopurine / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D012075:Remission, Spontaneous
D003561:Cytarabine; D007501:Iron; D015122:Mercaptopurine; D001215:Asparaginase; D011241:Prednisone; D003630:Daunorubicin